🔗 Visit the ClinicalTrials.gov page for NCT00902928
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | New antithrombotic drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. | Chest | 2012 | 1.59 |
| 2 | The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor. | Nat Rev Drug Discov | 2010 | 1.33 |
| 3 | Impact of venous thromboembolism on clinical management and therapy after hip and knee arthroplasty. | Can J Surg | 2011 | 0.85 |
| 4 | Darexaban (YM150) versus enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a randomised phase IIb dose confirmation study (ONYX-3). | Thromb Haemost | 2013 | 0.76 |
| 5 | New anticoagulants for the prevention of venous thromboembolism. | Drug Des Devel Ther | 2010 | 0.76 |